United States· US:68788-7813_4532fe49-8f6a-41d6-acbd-ff79e24af346
Quetiapine Fumarate
A quetiapine product containing quetiapine fumarate, registered in United States by Preferred Pharmaceuticals Inc.. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Quetiapine is registered in 18 of 19 countries.
Countries holding a registration under ATC N05AH04 (quetiapine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Quetiapine · ATC N05AH04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of quetiapine costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.19 in United States to $3.93 in Switzerland — a ×20 gap.
- United States: $0.19 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Quetiapine · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.93
- ES Spain$2.46
- IT Italy$2.42
- FR France$0.90
- US United States$0.19 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- QUETIAPINE FUMARATE
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- N05AH04
- ATC class
- Quetiapine
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 5
- ndc1168788-7813-1
- ndc1168788-7813-3
- ndc1168788-7813-6
- ndc1168788-7813-8
- ndc1168788-7813-9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
559 interactions on record for quetiapine.
Graded by severity as the source publishes them — 61 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Quetiapine · interactions on record
559 records
- 61 severe
- 281 moderate
- 7 minor
- 132 info
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
78 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Quetiapine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainKETYALIX 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULAItalfarmaco S.A.
- CzechiaQUETIAPIN NEURAXPHARMNeuraxpharm Bohemia s.r.o., Praha
- ItalyQUETIAPINA PENSA PHARMATOWA PHARMACEUTICAL S.P.A.
- NetherlandsQuetiapine Accord 50 mg filmomhulde tablettenAccord Healthcare B.V.
- SwedenQuetiapine Accord 50 mg Filmdragerad tablettAccord Healthcare B.V.
- BelgiumQuetiapin Sandoz 50 mgSandoz
- United KingdomAtrolak XL 150mg tabletsAccord-UK Ltd
- FinlandBiquetanSTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Quetialan, Quetialan 4 Tage Startpackung
- Belgium · Ketyalix, Quetiapin Retard Sandoz
- Bulgaria · Centroqueen, Бревенокс
- Cyprus · Aquetia, Ketipine
- Czechia · Derin, Derin Prolong
- Germany · Aquetia, Desiquet
- Denmark · Antoreq, Biquetan
- Estonia · Ketipinor, Kventiax
- Spain · Atrolak Prolong, Ketyalix
- Finland · Biquetan, Ketipinor
- France · Lp, Queliva
- United Kingdom (Northern Ireland) · Alaquet Xl, Atrolak Xl
- Greece · Anaquetan Xr, Aquetia
- Croatia · Kventiax, Kventiax Sr
- Hungary · Ketilept, Ketilept Prolong
- Ireland · Notiabolfen Xl, Quentiax Sr
- Iceland · Quetiapin Actavis, Quetiapin Krka
- Italy · Akelya, Quentiax
- Lithuania · Hedonin, Ketipinor
- Luxembourg · Aquetia, Quetiapine Eg
- Latvia · Ketipinor, Kventiax
- Malta · Quetex, Quetex Xr 50mg
- Netherlands · Aquetia, Quetiapine
- Norway · Quetiapin Krka, Quetiapin Orion
- Poland · Apotiapina, Apotiapina Pr
- Portugal · Anaquetan Xr, Aquetia
- Romania · Kventiax, Kventiax Ep
- Sweden · Biquetan, Quetiapin Hexal
- Slovenia · Kvelux, Kvelux Sr
- Slovakia · Derin, Derin Prolong
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd29bbb5-80d3-45dc-9a14-b7e19821eaeb GET /v1/drugs/cd29bbb5-80d3-45dc-9a14-b7e19821eaeb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "QUETIAPINE FUMARATE",
"productndc": "68788-7813",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA201504",
"marketing_category": "ANDA"
}See everything about quetiapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.